Estados Unidos - inglês - NLM (National Library of Medicine)

nelco laboratories, inc. - acacia baileyana pollen (unii: 59wav8g5x5) (acacia baileyana pollen - unii:59wav8g5x5) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Estados Unidos - inglês - NLM (National Library of Medicine)

nelco laboratories, inc. - acacia baileyana pollen (unii: 59wav8g5x5) (acacia baileyana pollen - unii:59wav8g5x5) - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - glecaprevir, quantity: 50 mg; pibrentasvir, quantity: 20 mg - granules - excipient ingredients: copovidone; tocofersolan; propylene glycol monocaprylate; colloidal anhydrous silica; croscarmellose sodium; sodium stearylfumarate; purified water; titanium dioxide; lactose monohydrate; hypromellose; iron oxide red; macrogol 3350; iron oxide yellow - maviret is indicated for the treatment of adult and paediatric patients 3 years and older with chronic hepatitis c virus (hcv) genotype (gt) 1, 2, 3, 4, 5, or 6 infection with or without compensated cirrhosis. this includes patients with hcv gt1 infection who were previously treated with either a regimen of an ns5a inhibitor or with an ns3/4a protease inhibitor but not both classes of inhibitors (see 4.2 dose and method of administration and 5.1 pharmacodynamic properties ? clinical trials).

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - glecaprevir, quantity: 100 mg; pibrentasvir, quantity: 40 mg - tablet, film coated - excipient ingredients: propylene glycol monocaprylate; tocofersolan; croscarmellose sodium; sodium stearylfumarate; copovidone; colloidal anhydrous silica; titanium dioxide; lactose monohydrate; hypromellose; iron oxide red; macrogol 3350 - maviret is indicated for the treatment of adult and paediatric patients 3 years and older with chronic hepatitis c virus (hcv) genotype (gt) 1, 2, 3, 4, 5, or 6 infection with or without compensated cirrhosis. this includes patients with hcv gt1 infection who were previously treated with either a regimen of an ns5a inhibitor or with an ns3/4a protease inhibitor but not both classes of inhibitors (see 4.2 dose and method of administration and 5.1 pharmacodynamic properties ? clinical trials).

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - glecaprevir, quantity: 100 mg; pibrentasvir, quantity: 40 mg - tablet, film coated - excipient ingredients: propylene glycol monocaprylate; tocofersolan; croscarmellose sodium; sodium stearylfumarate; copovidone; colloidal anhydrous silica; titanium dioxide; lactose monohydrate; hypromellose; iron oxide red; macrogol 3350 - maviret is indicated for the treatment of adult and paediatric patients 3 years and older with chronic hepatitis c virus (hcv) genotype (gt) 1, 2, 3, 4, 5, or 6 infection with or without compensated cirrhosis. this includes patients with hcv gt1 infection who were previously treated with either a regimen of an ns5a inhibitor or with an ns3/4a protease inhibitor but not both classes of inhibitors (see 4.2 dose and method of administration and 5.1 pharmacodynamic properties ? clinical trials).

Estados Unidos - inglês - NLM (National Library of Medicine)

amorepacific corporation - octinoxate 7%, titanium dioxide 4.15%, zinc oxide 9.8% - sunscreen - helps prevent sunburn. - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun.

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

tessenderlo kerley, inc - carbaryl - suspension concentrate - carbaryl carbamate-methylcarbamate active 500.0 g/l - insecticide - apple | apricot | avocado | bean | bowling green | cereal crop | commercial/industrial land | cotton | cucurbit | duboisia or co - ant | armyworm | australian plague locust | beetle | black scarab beetle | blackheaded pasture cockchafer | bronze orange bug | brown planthopper | cabbage moth | cabbage white butterfly | castor oil looper | caterpillar | chewing insect | citrus leaf-eating caterpillar | cluster caterpillar | codling moth | common mango scale | cornelian butterfly | cucurbit stemborer | cutworm - agrotis spp. | early fruit caterpillar | elm leaf beetle | english wasp | european earwig | european honey bee | european wasp | false wireworm - celibe spp. | fig leafhopper | flea | fruit sucking (fruitpiercing) moth | fruit thinning | fruit-tree borer moth | fuller's rose weevil | grass caterpillar | grass-crown mealybug | grasshopper | green treehopper | green vegetable bug | helicoverpa spp. | lawn grub | leaf beetle | leaf-eating beetle | leaf-eating ladybird - epilachna spp. | leaf-eating ladybird-e. guttatopustulata | leaf-eating looper | leafhopper | leafminer caterpillar | leafroller moth | light brown apple moth | looper

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - chlorpyrifos+maldison - group 1b insecticide

Austrália - inglês - APVMA (Australian Pesticides and Veterinary Medicines Authority)

indigo specialty products pty ltd - simazine - suspension concentrate - simazine triazine active 500.0 g/l - herbicide

África do Sul - inglês - South African Health Products Regulatory Authority (SAHPRA)

weleda -